NCT01071694View on ClinicalTrials.gov

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)

Patients receiving Betaferon according to routine clinical practice

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY